ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Association Between First-Trimester Gestational Weight Gain and the Risks of Gestational Diabetes Mellitus and Macrosomia.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the association between first-trimester gestational weight gain and the risks of gestational diabetes mellitus (GDM) and macrosomia. Patients and Methods: This single-center retrospective cohort study was based on our hospital's obstetric record-establishment database. Between January 2022 and January 2025, 516 women with singleton pregnancies were screened, and 500 eligible women were included in the final analysis. Data on pre-pregnancy weight, first-trimester weight, demographic characteristics, fasting plasma glucose, dietary energy intake, and physical activity were collected. Participants were categorized into low, appropriate, and excessive gestational weight gain groups according to weekly gestational weight gain during the first trimester. Multivariable logistic regression, ROC curve analysis, and sensitivity analyses across pre-pregnancy BMI strata were performed. Results: The incidence of GDM (63.1%) and macrosomia (69.0%) was higher in excessive weight gain group. Excessive gestational weight gain in the first trimester was associated with higher odds of GDM (OR = 2.209, 95% CI: 1.313-3.717) and macrosomia (OR = 2.103, 95% CI: 1.235-3.579). Sensitivity analysis across BMI strata suggested a consistently elevated risk trend in the excessive weight gain group. Conclusion: Excessive gestational weight gain during the first trimester was associated with higher risks of GDM and macrosomia. These findings suggest that first-trimester gestational weight gain may be useful as a potential early risk marker, although the conclusions should be interpreted cautiously and require confirmation in future prospective studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.